Circulating Fibrinolytic Activator and Hemorrhagic Diathesis
- 1 July 1963
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 158 (1), 117-125
- https://doi.org/10.1097/00000658-196307000-00021
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. II. THE SIGNIFICANCE, MECHANISM AND CONSEQUENCES OF DEFECTIVE FIBRIN POLYMERIZATION*JCI Insight, 1962
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. I. THE SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS*JCI Insight, 1962
- Problems in Hemostasis During Open-Heart Surgery III. Epsilon Amino Caproic Acid as an Inhibitor of Plasminogen Activator ActivityAnnals of Surgery, 1962
- The Use of Fat Emulsion Intravenously in the Control of Hemorrhage Due to Thrombolysin ActivitySouthern Medical Journal, 1961
- The Fibrinolytic Enzyme System in Normal, Hemorrhagic and Disease States1JCI Insight, 1958
- Plasma fibrinogen determination; a rapid titration method.1956
- PLASMA FIBRINOLYTIC ACTIVITY IN CIRRHOSIS OF THE LIVERThe Lancet, 1956
- Hemorrhagic States during PregnancyNew England Journal of Medicine, 1955
- Abnormal plasma proteolytic activity; diagnosis and treatment.1954
- Defective Blood Coagulation Following Pulmonary SurgeryNew England Journal of Medicine, 1954